107 related articles for article (PubMed ID: 25753487)
1. The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes.
Mead L; Porteous L; Tait M; Stoker R; Payne S; Calvert C; Maxwell D; Katikireddi SV
J Med Screen; 2015 Jun; 22(2):106-8. PubMed ID: 25753487
[TBL] [Abstract][Full Text] [Related]
2. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study.
Palmer CK; Thomas MC; von Wagner C; Raine R
Br J Cancer; 2014 Apr; 110(7):1705-11. PubMed ID: 24619071
[TBL] [Abstract][Full Text] [Related]
3. Factors contributing to the low participation rate of Turkish women to a breast cancer screening program in Antwerp, Belgium.
Topal F; Van Roosbroeck S; Van Hal G; Jacquemyn Y
Eur J Gynaecol Oncol; 2015; 36(5):520-3. PubMed ID: 26513875
[TBL] [Abstract][Full Text] [Related]
4. [Reasons for non-participation in mammography screening--a survey in Schleswig-Holstein, Germany].
Schnoor M; Hallof A; Hergert-Lüder D; Katalinic A; Waldmann A
Dtsch Med Wochenschr; 2013 Nov; 138(45):2289-94. PubMed ID: 24163164
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer screening programmes: challenging the coexistence with opportunistic mammography.
Ouédraogo S; Dabakuyo-Yonli TS; Amiel P; Dancourt V; Dumas A; Arveux P
Patient Educ Couns; 2014 Dec; 97(3):410-7. PubMed ID: 25282326
[TBL] [Abstract][Full Text] [Related]
6. [Attendance in the Norwegian Breast Cancer Screening Programme].
Sebuødegård S; Sagstad S; Hofvind S
Tidsskr Nor Laegeforen; 2016 Sep; 136(17):1448-51. PubMed ID: 27686204
[TBL] [Abstract][Full Text] [Related]
7. Association between comorbidity and participation in breast and cervical cancer screening: A systematic review and meta-analysis.
Diaz A; Kang J; Moore SP; Baade P; Langbecker D; Condon JR; Valery PC
Cancer Epidemiol; 2017 Apr; 47():7-19. PubMed ID: 28086199
[TBL] [Abstract][Full Text] [Related]
8. European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France.
Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Pornet C; Sarlin N; Lunaud P; Desmidt P; Quantin C; Chauvin F; Dancourt V; Arveux P
Prev Med; 2014 Jun; 63():103-8. PubMed ID: 24345603
[TBL] [Abstract][Full Text] [Related]
9. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
[TBL] [Abstract][Full Text] [Related]
10. Effect of issuing an invitation for breast cancer screening to women aged 65 to 69.
Hendry PJ; Entwistle C
J Med Screen; 1996; 3(2):88-9. PubMed ID: 8849767
[TBL] [Abstract][Full Text] [Related]
11. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
12. [Study of non-participation in the breast cancer screening program in the city of Valencia (Spain)].
Alcaraz M; Lluch A; Miranda J; Pereiro I; Salas MD
Gac Sanit; 2002; 16(3):230-5. PubMed ID: 12057178
[TBL] [Abstract][Full Text] [Related]
13. Non-participation in breast cancer screening for women with chronic diseases and multimorbidity: a population-based cohort study.
Jensen LF; Pedersen AF; Andersen B; Vestergaard M; Vedsted P
BMC Cancer; 2015 Oct; 15():798. PubMed ID: 26502879
[TBL] [Abstract][Full Text] [Related]
14. Knowledge, barriers and attitudes towards breast cancer mammography screening in jordan.
Abu-Helalah MA; Alshraideh HA; Al-Serhan AA; Kawaleet M; Nesheiwat AI
Asian Pac J Cancer Prev; 2015; 16(9):3981-90. PubMed ID: 25987073
[TBL] [Abstract][Full Text] [Related]
15. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
16. Attending the breast screening programme after breast cancer treatment: a population-based study.
de Munck L; Kwast A; Reiding D; de Bock GH; Otter R; Willemse PH; Siesling S
Cancer Epidemiol; 2013 Dec; 37(6):968-72. PubMed ID: 24075800
[TBL] [Abstract][Full Text] [Related]
17. Non-participation in breast cancer screening among previous cancer patients.
Virgilsen LF; Pedersen AF; Andersen B; Vedsted P
J Cancer Res Clin Oncol; 2018 Oct; 144(10):1959-1966. PubMed ID: 30097713
[TBL] [Abstract][Full Text] [Related]
18. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
19. Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?
Hoff SR; Klepp O; Hofvind S
J Med Screen; 2012 Dec; 19(4):177-83. PubMed ID: 23486698
[TBL] [Abstract][Full Text] [Related]
20. Invitation coverage and participation in Italian cervical, breast and colorectal cancer screening programmes.
Giorgi Rossi P; Carrozzi G; Federici A; Mancuso P; Sampaolo L; Zappa M
J Med Screen; 2018 Mar; 25(1):17-23. PubMed ID: 28614991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
